"10.1371_journal.pone.0068329","plos one","2013-07-17T00:00:00Z","Rolando Herrero; Wim Quint; Allan Hildesheim; Paula Gonzalez; Linda Struijk; Hormuzd A Katki; Carolina Porras; Mark Schiffman; Ana Cecilia Rodriguez; Diane Solomon; Silvia Jimenez; John T Schiller; Douglas R Lowy; Leen-Jan van Doorn; Sholom Wacholder; Aimée R Kreimer; for the CVT Vaccine Group","Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France; DDL Diagnostic Laboratory, Rijswijk, The Netherlands; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America; Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Guanacaste, Costa Rica; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America","¶Membership of the CVT Vaccine Group is provided in the Acknowledgments","JTS and DRL report that they are named inventors on US Government-owned HPV vaccine patents (US 5,437,951; US 5,709,996; US 5,716,620; US 5,744,142; US 5,756,284; US 5,871,998; US 5,985,610; US 7,220,419; and US 7,361,356: Self-assembling recombinant papillomavirus capsid proteins) that are licensed to GlaxoSmithKline and Merck and for which the National Cancer Institute receives licensing fees. They are entitled to limited royalties as specified by federal law. The following authors: Wim Quint, Leen-Jan van Doorn and Linda Struijk are employed by the commercial company DDL Diagnostic Laboratory, Rijswijk, The Netherlands. Vaccine was provided for our trial by GlaxoSmithKline Biologicals (GSK), under a Clinical Trials Agreement with the National Cancer Institute. GSK also provided support for aspects of the trial associated with regulatory submission needs of the company under FDA BB-IND 7920. The other authors declare that they have no conflicts of interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Rolando Herrero","RH",17,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
